Current Psychiatry Reports

, Volume 11, Issue 3, pp 205–210 | Cite as

Prostate cancer: Issues in psychosomatic medicine

Article

Abstract

Prostate cancer is now a chronic condition. Screening, diagnosis, and treatment pose specific psychosocial challenges for men diagnosed and surviving with prostate cancer. Depression, anxiety, and cognitive impairment lead to emotional distress and difficulty coping. Treatments for psychosocial distress are targeted at couples and individuals. Lifestyle modification may improve coping and quality-of-life indicators.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lin K, Lipsitz R, Miller T, Janakiraman S: Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2008, 149:192–199.PubMedGoogle Scholar
  2. 2.
    Pinto B, Trunzo J: Health behaviors during and after a cancer diagnosis, cancer survivorship: resilience across the lifespan. Cancer 2005, 104(11 Suppl):2614–2623.PubMedCrossRefGoogle Scholar
  3. 3.
    Stein K, Syrjala K, Andrykowski M: Physical and psychological long-term and late effects of cancer. Cancer 2008, 112(11 Suppl):2577–2592.PubMedCrossRefGoogle Scholar
  4. 4.
    Bloch S, Love A, Macvean M, et al.: Psychological adjustment of men with prostate cancer: a review of the literature. Biopsychosocial Med 2007, 1:2.CrossRefGoogle Scholar
  5. 5.
    Vitek L, Rosenzweig MQ, Stolling S: Distress in patients with cancer: definition, assessment, and suggested interventions. Clin J Oncol Nurs 2007, 11:413–418.PubMedCrossRefGoogle Scholar
  6. 6.
    National Priorities Partnership sets action agenda to improve healthcare and cut waste during time of severe economic strain [press release]. Washington, DC: National Priorities Partnership; November 17, 2008.Google Scholar
  7. 7.
    Vachon M: The emotional problems of the patient in palliative medicine. In Oxford Textbook of Palliative Medicine. Edited by Doyle D, Hanks G, Cherney N, et al. Oxford: Oxford University Press; 2005:961–985.Google Scholar
  8. 8.
    Ferrell B, Paice J, Koczywas M: New standards and implications for improving the quality of supportive oncology practice. J Clin Oncol 2008, 26:3824–3831.PubMedCrossRefGoogle Scholar
  9. 9.
    Cox J, Amling C: Current decision-making in prostate cancer therapy. Curr Opin Urol 2008, 18:275–278.PubMedCrossRefGoogle Scholar
  10. 10.
    Mitchell R, Chang S: Current controversies in the treatment of high-risk prostate cancer. Curr Opin Urol 2008, 18:263–268.PubMedCrossRefGoogle Scholar
  11. 11.
    Kunkel E, Bakker J, Myers R, et al.: Biopsychosocial aspects of prostate cancer. Psychosomatics 2000, 41:85–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Nelson C, Lee J, Gamboa M, Roth A: Cognitive effects of hormone therapy in men with prostate cancer. Cancer 2008, 5:1097–1106.CrossRefGoogle Scholar
  13. 13.
    DiBlasio CJ, Hammett J, Malcolm JB, et al.: Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer. Can J Urol 2008, 15:4249–4256.PubMedGoogle Scholar
  14. 14.
    O’Neill B, Fallon M: ABC of palliative care. Principles of palliative care and pain control. BMJ 1997, 315:801–804.PubMedGoogle Scholar
  15. 15.
    Brindle LA, Oliver SE, Dedman D, et al.: Measuring the psychological impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int 2006, 98:777–782.PubMedCrossRefGoogle Scholar
  16. 16.
    Shaha M, Cox C, Talman K, Kelly D: Uncertainty in breast, prostate, and colorectal cancer: implications for supportive care. J Nurs Scholarsh 2008, 40:1, 60–67.CrossRefGoogle Scholar
  17. 17.
    Bhatnagar V, Kaplan R: Treatment options for prostate cancer: evaluating the evidence. Am Fam Physician 2005, 71:1915–1922.PubMedGoogle Scholar
  18. 18.
    Nordin K, Berglund G, Glimelius B, Sjoeeden PO: Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer 2001, 37:376–384.PubMedCrossRefGoogle Scholar
  19. 19.
    Hinz A, Krauss O, Stolzenburg JU, et al.: Anxiety and depression in patients with prostate cancer and other urogenital cancer: a longitudinal study. Urol Oncol 2008 Apr 25 (Epub ahead of print).Google Scholar
  20. 20.
    Bisson JI, Chubb HL, Mason M, et al.: The prevalence and predictors of psychological distress in patients with early localized prostate cancer. BJU Int 2002, 90:56–61.PubMedCrossRefGoogle Scholar
  21. 21.
    Walker J, Watres R, Murray G, et al.: Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 2008, 26:4725–4730.PubMedCrossRefGoogle Scholar
  22. 22.
    Llorente M, Burke M, Gregory G, et al.: Prostate cancer: a significant risk for late-life suicide. Am J Geriatr Psychiatry 2005, 13:195–201.PubMedGoogle Scholar
  23. 23.
    Reich M: Depression and cancer: recent data on clinical issues, research challenges and treatment approaches. Curr Opin Oncol 2008, 20:353–359.PubMedCrossRefGoogle Scholar
  24. 24.
    Kornblith A, Herr HW, Ofman US, et al.: Quality of life of patients with prostate cancer and their spouses. Cancer 1994, 73:2791–2802.PubMedCrossRefGoogle Scholar
  25. 25.
    Lawlor PG, Bruera ED: Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002, 16:701–714.PubMedCrossRefGoogle Scholar
  26. 26.
    Tremont-Lukats I, Bobustuc G, Lagos GK, et al.: Brain metastasis from prostate carcinoma: the M.D. Anderson Cancer Center experience. Cancer 2003, 98:363–368.PubMedCrossRefGoogle Scholar
  27. 27.
    Leonard M, Agar M, Mason C, Lawlor P: Delirium issues in palliative care settings. J Psychosom Res 2008, 65:289–298.PubMedCrossRefGoogle Scholar
  28. 28.
    Tewari AK, Gold HT, Demers RY, et al.: Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer. Urology 2009, 73:624–630.PubMedCrossRefGoogle Scholar
  29. 29.
    Campbell L, Keefe F, Scipio C: Facilitating research participation and improving quality of life for African American prostate cancer survivors and their intimate partners. A pilot study of telephone-based coping skills training. Cancer 2007, 109(2 Suppl):414–424.PubMedCrossRefGoogle Scholar
  30. 30.
    Jennings D: Love in the time of prostate cancer, prostate cancer journal. New York Times. February 9, 2009. http://well.blogs.nytimes.com/2009/02/09/love-in-the-time-of-prostate-cancer/. Accessed February 20, 2009.
  31. 31.
    Galbraith M, Arechiga A, Ramirez J, Pedro L: Prostate cancer survivors’ and partners’ self-reports of health-related quality of life, treatment symptoms, and marital satisfaction 2.5–5.5 years after treatment. Oncol Nurs Forum 2005, 2:E30–E41.CrossRefGoogle Scholar
  32. 32.
    Jennings D: Real men get prostate cancer, prostate cancer journal. New York Times. November 18, 2008. http://well.blogs.nytimes.com/2008/11/18/real-men-get-prostate-cancer/. Accessed March 1, 2009.
  33. 33.
    Kiss A, Meryn S: Effect of sex and gender on psychological aspects of prostate and breast cancer. BMJ 2001, 323:1055–1058.PubMedCrossRefGoogle Scholar
  34. 34.
    Carlson L, Speca M, Faris P, Patel K: One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain Behav Immun 2007, 21:1038–1049.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Thomas Jefferson UniversityPhiladelphiaUSA

Personalised recommendations